Novel mutations in HTRA1-related cerebral small vessel disease and comparison with CADASIL

Chen Zhang1, Honghua Zheng2, Xin Li2

  • 1Department of Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Insights

Most familial cerebral small vessel disease (CSVD) patients in China have heterozygous HTRA1 mutations. This study differentiates HTRA1-CSVD from CADASIL using distinct clinical and neuroimaging features.

Area of Science:

  • Genetics
  • Neurology
  • Vascular Biology

Background:

  • Familial cerebral small vessel disease (CSVD) can be caused by heterozygous or homozygous mutations in the HTRA1 gene.
  • Heterozygous HTRA1-related CSVD shares clinical and neuroimaging similarities with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Purpose of the Study:

  • To characterize the genotypic and phenotypic features of HTRA1-related CSVD in a Chinese cohort.
  • To compare the clinical and neuroimaging characteristics of heterozygous HTRA1-related CSVD with CADASIL.

Main Methods:

  • Genetic sequencing was performed on unrelated patients with suspected familial CSVD from China.
  • Clinical and neuroimaging data of patients with heterozygous HTRA1-related CSVD and CADASIL were analyzed and compared.

Main Results:

  • Nine heterozygous and one homozygous HTRA1 mutations were identified, with seven novel mutations.
  • Heterozygous HTRA1-CSVD patients exhibited a higher prevalence of spine disorders and less anterior temporal lobe white matter hyperintensities compared to CADASIL patients (p < 0.001).

Conclusions:

  • The majority of HTRA1-related CSVD cases in China are associated with heterozygous HTRA1 mutations.
  • Distinct extra-neurological and neuroimaging findings help differentiate heterozygous HTRA1-CSVD from CADASIL.
  • This research expands the known spectrum of HTRA1 mutations associated with CSVD.
Abstract